Dr. Paresh Dandona at the University at Buffalo Jacobs School of Medicine may have discovered a medication that could change the way Type 1 diabetes is treated.
Our endocrinology month in review for September 2023 spotlights news related to semaglutide and a pair of articles offering a deep dive into comorbidities in type 1 and type 2 diabetes.
In a new research, scientists have found that Semaglutide, a drug used for weight loss, might contribute to reducing or completely eroding the insulin shots in people diagnosed with Type 1 diabetes.